期刊文献+

甘精胰岛素对血糖控制不良2型糖尿病患者的临床疗效 被引量:5

暂未订购
导出
摘要 目的探讨甘精胰岛素对血糖控制不良2型糖尿病(T2DM)患者的临床疗效。方法将60例T2DM患者随机分为两组各30例,A组皮下注射甘精胰岛素,B组皮下注射诺和锐30,两组疗程均为12周。治疗前后检测两组空腹血糖、餐后2 h血糖、血糖波动程度,观察其低血糖发生率。结果在血糖控制方面,两组比较无统计学差异(P>0.05);但A组的血糖波动程度、低血糖发生率明显低于B组(P均<0.05)。结论对血糖控制不良T2DM患者,甘精胰岛素与诺和锐30的降糖疗效相当,但前者的血糖波动程度及低血糖发生率明显低于后者,可提高患者的顺应性。
出处 《山东医药》 CAS 北大核心 2011年第25期59-60,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

  • 1Kann PH, Washcher T, Zaekova V, et al. Staring insulin therapy in type 2 diabetes : twice-daily biphasic insulin aspart 30 plus mefformin versus one daily insulin glargine plus glimepiride [ J ]. Exp Clin Endocrinol Diabetes, 2006,114(9) :527.
  • 2Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial randomized addition of glassine or human NPH insulin to oral therapy of type 2 diabetes patients[J]. Diabetes Care, 2003,26( 11 ) :3080- 3086.
  • 3Rosenstoek J, Sehwaiq2 SL, Clark C, et al. Basal insulin therapy in type 2 diabetes: 27-week eomparison of insulin glarglne( HOMg01 ) and NPH insulin[J]. Diabetes Care, 2001,24( 11 ) :631-636.
  • 4Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes AND a consensus algorithm for the initiation and adjustment of therapy [ J ]. Diabetes care, 2009,32 (5) :58.
  • 5Gonzale OM, Martjnez AE, Hemandez SE, et al. Effect of a nutritional liquid supplement designed for the patient with diabetes mellitus on the postprandial glucose state, insulin secretion and insulin sensitivity in healthy subjects [ J ]. Diabetes Obes Metab, 2006,8 (3) :331-335.
  • 6Sargin H, Sargin M, Altuntas Y, et al. Comparison of lunch and bedtime NPH insulin plus mealtime insulin lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes[J]. Diabetes Res Clin Pract, 2003,62(2) :79-86.

同被引文献45

  • 1杨文英.解读预混胰岛素类似物双时相门冬胰岛素30在临床实践中的使用[J].中华糖尿病杂志,2010,2(3). 被引量:15
  • 2王先令,陆菊明,潘长玉,母义明,窦京涛,巴建明.应用动态血糖监测系统评价甘精胰岛素作为基础胰岛素治疗的优越性[J].中华内分泌代谢杂志,2006,22(4):319-321. 被引量:60
  • 3文柳静.降糖药研究进展[J].中国药房,2007,18(23):1828-1831. 被引量:12
  • 4González-Ortiz M, Martínez-Abundis E, Hernández-Salazar E, et al. Effect of a nutritional liquid supplement designed for the patient with diabetes mellitus (Glucerna SR) on the postprandial glucose state, insulin secretion and insulin sensitivity in healthy subjects[J]. Diabetes Obes Metab,2006,8(3):331-315.
  • 5陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:717-718.
  • 6Nathan DM, Buse JB,Davidson MB,et al .Medical management of hyperglycemia in type2 diabetes AND a consensus algorithm for the initiation and adjustment of therapyfj].Diabetes care, 2009, 32(5). 58.
  • 7Kann PH,Washeher T,Zaekova V,et al. Staring insulin therapy in type 2 diabetes.twice--daily biphasic insulin aspart 30 plus melform- in versus one daily insulin glargine plus glimepiride[J]. Exp Ciin Endocrinol Diabetes, 2006,1 )4(9):527.
  • 8Gonzdlez-Ortiz M, Martinez-Abundis E, Herndndez- Salazar E, et al, Effect of a nutritional liquid supple- ment designed for the patient with diabetes mellitus (Glucerna SR) on the postprandial glucose state, insu- lin secretion and insulin sensitivity in healthy subjects [J]. Diabetes Obes Metab,2006,8(3) :331-315.
  • 9Boulton AJ. What you can not feel can hurt you[J] J Am Podiatr Med Assoc, 2010,100 (5) :349-352.
  • 10Retnakaran R, Yakubovich N, Qi Y, et al. The response to short- erm intensive insulin therapy in type 2 diabetes[ J]. Diabetes Obes Metab, 2010,12( 1 ) :65-71.

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部